Literature DB >> 20214585

Advantages of nanotechnology-based Chinese herb drugs on biological activities.

Sherry Huang1, Walter H Chang.   

Abstract

A number of new nanotechnology-based Chinese herb drugs have been developed that have efficient biopharmaceutical properties and desirable target characteristics. This offers several alternatives for medical applications. Nanoparticles of Chinese herb drugs possess many benefits, such as improving component solubility, enhancement of bioavailability, increasing absorbency of the organism, reducing medicinal herb doses, and achieving steady-state therapeutic levels of drugs over an extended period compared with traditional Chinese herb drug preparations. There are two basic techniques, 'bottom up' or 'top down', to prepare Chinese herb nanoparticles. Furthermore, specific surface modifications and new design strategies of Chinese herb drug nanoparticles are created to profit clinical applications. This review presents recent advances in nanotechnology-based Chinese herb drugs.

Mesh:

Substances:

Year:  2009        PMID: 20214585     DOI: 10.2174/138920009790274603

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  3 in total

1.  Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.

Authors:  Iris R Bell; Gary E Schwartz; Nancy N Boyer; Mary Koithan; Audrey J Brooks
Journal:  Eur J Integr Med       Date:  2013-04-01       Impact factor: 1.314

2.  Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice.

Authors:  Sherry Huang; Shu-Jen Chang; Miffy Yang; Justin Jin-Ching Chen; Walter H Chang
Journal:  Int J Nanomedicine       Date:  2011-07-01

3.  Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts.

Authors:  Marc Strasser; Peky Noriega; Raimar Löbenberg; Nádia Bou-Chacra; Elfriede M Bacchi
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.